Literature DB >> 31513583

Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.

Hanane Omichessan1,2, Gianluca Severi1,2,3, Vittorio Perduca1,4.   

Abstract

Mutational signatures refer to patterns in the occurrence of somatic mutations that might be uniquely ascribed to particular mutational process. Tumour mutation catalogues can reveal mutational signatures but are often consistent with the mutation spectra produced by a variety of mutagens. To date, after the analysis of tens of thousands of exomes and genomes from about 40 different cancer types, tens of mutational signatures characterized by a unique probability profile across the 96 trinucleotide-based mutation types have been identified, validated and catalogued. At the same time, several concurrent methods have been developed for either the quantification of the contribution of catalogued signatures in a given cancer sequence or the identification of new signatures from a sample of cancer sequences. A review of existing computational tools has been recently published to guide researchers and practitioners through their mutational signature analyses, but other tools have been introduced since its publication and, a systematic evaluation and comparison of the performance of such tools is still lacking. In order to fill this gap, we have carried out an empirical evaluation of the main packages available to date, using both real and simulated data. Among other results, our empirical study shows that the identification of signatures is more difficult for cancers characterized by multiple signatures each having a small contribution. This work suggests that detection methods based on probabilistic models, especially EMu and bayesNMF, have in general better performance than NMF-based methods.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31513583      PMCID: PMC6741849          DOI: 10.1371/journal.pone.0221235

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  32 in total

1.  Learning the parts of objects by non-negative matrix factorization.

Authors:  D D Lee; H S Seung
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

2.  Automatic relevance determination in nonnegative matrix factorization with the β-divergence.

Authors:  Vincent Y F Tan; Cédric Févotte
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2013-07       Impact factor: 6.226

Review 3.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

4.  EMu: probabilistic inference of mutational processes and their localization in the cancer genome.

Authors:  Andrej Fischer; Christopher J R Illingworth; Peter J Campbell; Ville Mustonen
Journal:  Genome Biol       Date:  2013-04-29       Impact factor: 13.583

5.  SomaticSignatures: inferring mutational signatures from single-nucleotide variants.

Authors:  Julian S Gehring; Bernd Fischer; Michael Lawrence; Wolfgang Huber
Journal:  Bioinformatics       Date:  2015-07-10       Impact factor: 6.937

6.  DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.

Authors:  Rachel Rosenthal; Nicholas McGranahan; Javier Herrero; Barry S Taylor; Charles Swanton
Journal:  Genome Biol       Date:  2016-02-22       Impact factor: 13.583

7.  Deciphering signatures of mutational processes operative in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Peter J Campbell; Michael R Stratton
Journal:  Cell Rep       Date:  2013-01-10       Impact factor: 9.423

8.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

9.  Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.

Authors:  S Kasar; J Kim; R Improgo; G Tiao; P Polak; N Haradhvala; M S Lawrence; A Kiezun; S M Fernandes; S Bahl; C Sougnez; S Gabriel; E S Lander; H T Kim; G Getz; J R Brown
Journal:  Nat Commun       Date:  2015-12-07       Impact factor: 14.919

10.  A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.

Authors:  Yuichi Shiraishi; Georg Tremmel; Satoru Miyano; Matthew Stephens
Journal:  PLoS Genet       Date:  2015-12-02       Impact factor: 5.917

View more
  15 in total

1.  MetaMutationalSigs: Comparison of mutational signature refitting results made easy.

Authors:  Palash Pandey; Sanjeevani Arora; Gail L Rosen
Journal:  Bioinformatics       Date:  2022-02-14       Impact factor: 6.937

Review 2.  Computational analysis of cancer genome sequencing data.

Authors:  Isidro Cortés-Ciriano; Doga C Gulhan; Jake June-Koo Lee; Giorgio E M Melloni; Peter J Park
Journal:  Nat Rev Genet       Date:  2021-12-08       Impact factor: 53.242

3.  Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures.

Authors:  Ammal Abbasi; Ludmil B Alexandrov
Journal:  DNA Repair (Amst)       Date:  2021-08-05

4.  SUITOR: Selecting the number of mutational signatures through cross-validation.

Authors:  Donghyuk Lee; Difei Wang; Xiaohong R Yang; Jianxin Shi; Maria Teresa Landi; Bin Zhu
Journal:  PLoS Comput Biol       Date:  2022-04-04       Impact factor: 4.779

Review 5.  Mutational signatures and processes in hepatobiliary cancers.

Authors:  Ekaterina Zhuravleva; Colm J O'Rourke; Jesper B Andersen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-10       Impact factor: 73.082

6.  iMutSig: a web application to identify the most similar mutational signature using shiny.

Authors:  Zhi Yang; Priyatama Pandey; Paul Marjoram; Kimberly D Siegmund
Journal:  F1000Res       Date:  2020-06-10

Review 7.  Mutational signatures: emerging concepts, caveats and clinical applications.

Authors:  Gene Koh; Andrea Degasperi; Xueqing Zou; Sophie Momen; Serena Nik-Zainal
Journal:  Nat Rev Cancer       Date:  2021-07-27       Impact factor: 60.716

8.  Chemically induced mutations in a MutaMouse reporter gene inform mechanisms underlying human cancer mutational signatures.

Authors:  Marc A Beal; Matthew J Meier; Danielle P LeBlanc; Clotilde Maurice; Jason M O'Brien; Carole L Yauk; Francesco Marchetti
Journal:  Commun Biol       Date:  2020-08-14

9.  pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.

Authors:  Jessada Thutkawkorapin; Jesper Eisfeldt; Emma Tham; Daniel Nilsson
Journal:  BMC Bioinformatics       Date:  2020-04-03       Impact factor: 3.169

10.  Characteristics of mutational signatures of unknown etiology.

Authors:  Xiaoju Hu; Zhuxuan Xu; Subhajyoti De
Journal:  NAR Cancer       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.